SEC Form 4 · accession 0001645470-19-000016
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 27, 2019
Accepted (ET)
Mar 6, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2019 | P | 5,000 | $0.0198 | A | 21,648,123 | D | |
| Common Stock | Feb 27, 2019 | P | 500 | $0.02 | A | 21,648,623 | D | |
| Common Stock | Feb 27, 2019 | P | 450 | $0.0199 | A | 21,649,073 | D | |
| Common Stock | Feb 27, 2019 | P | 50 | $0.0199 | A | 21,649,123 | D | |
| Common Stock | Feb 27, 2019 | P | 500 | $0.02 | A | 21,649,623 | D | |
| Common Stock | Feb 27, 2019 | P | 5,000 | $0.02 | A | 21,654,623 | D | |
| Common Stock | Feb 27, 2019 | P | 5,000 | $0.0212 | A | 21,659,623 | D | |
| Common Stock | Feb 27, 2019 | P | 5,000 | $0.021 | A | 21,664,623 | D | |
| Common Stock | Feb 28, 2019 | P | 5,000 | $0.0209 | A | 21,669,623 | D | |
| Common Stock | Mar 1, 2019 | P | 5,000 | $0.0214 | A | 21,674,623 | D | |
| Common Stock | Mar 4, 2019 | P | 5,000 | $0.021 | A | 21,679,623 | D | |
| Common Stock | Mar 4, 2019 | P | 5,000 | $0.0205 | A | 21,684,623 | D | |
| Common Stock | Mar 4, 2019 | P | 5,000 | $0.0214 | A | 21,689,623 | D |
Table II — derivative securities
No Table II lines on this filing.